- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05262283
Has The COVID-19 Pandemic Affected Injury in Football?
March 1, 2022 updated by: Nurhayat KORKMAZ, Karadeniz Technical University
Has The COVID-19 Pandemic Affected Injury in Football? Example of a Professional Football Team
This study aims to compare the injuries that occurred in the football players after the isolation and lack of training caused by New Coronavirus Disease (COVID-19), with the previous season, based on the example of a professional football team in Turkey.
Study Overview
Detailed Description
This study aims to compare the injuries that occurred in the football players who faced an intense match tempo after the isolation and lack of training caused by COVID-19, as well as the stress and uncertainty, with the previous season, based on the example of a professional football team in Turkey.
Injury follow-up data were examined.
Study Type
Observational
Enrollment (Actual)
24
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Trabzon, Turkey, 61000
- Karadeniz Technical University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Sampling Method
Probability Sample
Study Population
Participants consist of professional football players who have a contract with the A team.
Description
Inclusion Criteria:
- Having a musculoskeletal injury during the official match or team training in the 2019-2020 or 2020-2021 season
Exclusion Criteria:
- Signing a contract with Trabzonspor A Team in the 2020-2021 season
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
2019-2020 season
Injuries in the first 26 games of 2019-2020
|
No intervention was made.
|
|
2020-2021 season
Injuries in the first 26 games of 2020-2021 in the new post-COVID season
|
No intervention was made.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of injuries
Time Frame: Change of data in the first 26 matches of the 2019-2020 and 2020-2021 seasons
|
The number of injuries in the two seasons was recorded separately.
|
Change of data in the first 26 matches of the 2019-2020 and 2020-2021 seasons
|
|
Injury time
Time Frame: Change of data in the first 26 matches of the 2019-2020 and 2020-2021 seasons
|
Training injuries, Match injuries
|
Change of data in the first 26 matches of the 2019-2020 and 2020-2021 seasons
|
|
Injury severity
Time Frame: Change of data in the first 26 matches of the 2019-2020 and 2020-2021 seasons
|
Minor, moderate, major
|
Change of data in the first 26 matches of the 2019-2020 and 2020-2021 seasons
|
|
Injury type
Time Frame: Change of data in the first 26 matches of the 2019-2020 and 2020-2021 seasons
|
Sprain, strain, fracture, contision, other
|
Change of data in the first 26 matches of the 2019-2020 and 2020-2021 seasons
|
|
Injury location
Time Frame: Change of data in the first 26 matches of the 2019-2020 and 2020-2021 seasons
|
Foot, ankle, calf, knee, thigh, hip, groin, lumbal
|
Change of data in the first 26 matches of the 2019-2020 and 2020-2021 seasons
|
|
Injured tissue
Time Frame: Change of data in the first 26 matches of the 2019-2020 and 2020-2021 seasons
|
muscle, tendon, tendon bone junction, capsule, ligament, bone, aponeurosis, meniscus
|
Change of data in the first 26 matches of the 2019-2020 and 2020-2021 seasons
|
|
Injured side
Time Frame: Change of data in the first 26 matches of the 2019-2020 and 2020-2021 seasons
|
Left, right
|
Change of data in the first 26 matches of the 2019-2020 and 2020-2021 seasons
|
|
Injury mechanism
Time Frame: Change of data in the first 26 matches of the 2019-2020 and 2020-2021 seasons
|
noncontact, contact
|
Change of data in the first 26 matches of the 2019-2020 and 2020-2021 seasons
|
|
Rule violation
Time Frame: Change of data in the first 26 matches of the 2019-2020 and 2020-2021 seasons
|
Opponent, no
|
Change of data in the first 26 matches of the 2019-2020 and 2020-2021 seasons
|
|
Recurrence
Time Frame: Change of data in the first 26 matches of the 2019-2020 and 2020-2021 seasons
|
Yes, no
|
Change of data in the first 26 matches of the 2019-2020 and 2020-2021 seasons
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Training
Time Frame: Change of data in the first 26 matches of the 2019-2020 and 2020-2021 seasons
|
The number of days away from training
|
Change of data in the first 26 matches of the 2019-2020 and 2020-2021 seasons
|
|
Missed Matches
Time Frame: Change of data in the first 26 matches of the 2019-2020 and 2020-2021 seasons
|
Number of official matches missed
|
Change of data in the first 26 matches of the 2019-2020 and 2020-2021 seasons
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 26, 2021
Primary Completion (Actual)
May 30, 2021
Study Completion (Actual)
June 30, 2021
Study Registration Dates
First Submitted
February 28, 2022
First Submitted That Met QC Criteria
March 1, 2022
First Posted (Actual)
March 2, 2022
Study Record Updates
Last Update Posted (Actual)
March 2, 2022
Last Update Submitted That Met QC Criteria
March 1, 2022
Last Verified
March 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KTU-NK-TS-01
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.